Satisfaction with Prophylactic Mastectomy and Breast Reconstruction in Genetically Predisposed Women-Reference-Cited by-同舟云学术

Satisfaction with Prophylactic Mastectomy and Breast Reconstruction in Genetically Predisposed Women

Published:2006-05 Issue:6 Volume:117 Page:1675-1682
ISSN:0032-1052
Container-title:Plastic and Reconstructive Surgery
language:en
Short-container-title:Plastic and Reconstructive Surgery

Author:

Bresser Paula J. C.,Seynaeve Caroline,Gool Arthur R. Van,Brekelmans Cecile T.,Meijers-Heijboer Hanne,van Geel Albert N.,Menke-Pluijmers Marian B.,Duivenvoorden Hugo J.,Klijn Jan G. M.,Tibben Aad

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference24 articles.

1. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

3. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

4. Population-based study of risk of breast cancer in carriers of BRCA2 mutation

5. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effectiveness of transaxillary single‐port endoscopic surgery in the treatment of breast benign tumor;World Journal of Surgery;2024-07-30

2. The impact of prophylactic mastectomy on sexual well-being: a systematic review;Sexual Medicine Reviews;2024-01-05

3. Hereditary Breast Cancer Non-CDH1 Associated;Hereditary Gastric and Breast Cancer Syndrome;2023

4. Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study;Hereditary Cancer in Clinical Practice;2022-12-19

5. Breast Reconstruction Decision Aids Decrease Decisional Conflict and Improve Decisional Satisfaction: A Randomized Controlled Trial;Plastic & Reconstructive Surgery;2022-11-08